- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Raytel implements reverse stock split
On May 23, in hopes of boosting its stock price above the minimum $1 per share required to keep its Nasdaq listing, Raytel Medical underwent a one-for-three reverse stock split. Doing so reduced the number of outstanding shares of common stock from
On May 23, in hopes of boosting its stock price above the minimum $1 per share required to keep its Nasdaq listing, Raytel Medical underwent a one-for-three reverse stock split. Doing so reduced the number of outstanding shares of common stock from approximately 8.8 million to 2.9 million. Shareholders have been asked to return their stock certificates representing shares of the old common stock. They will be given cash, based on the May 23 closing price, in lieu of any fractional shares. On May 24, trading closed at $1.8 per share. The upward swing continued, with Raytel closing May 30 at $2.25.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
MRI-Based AI Model Shows Promise in Predicting Lymph Node Metastasis with Breast Cancer
April 15th 2024For the prediction of axillary lymph node metastasis in patients with breast cancer, an MRI-based, 4D convolutional neural network model demonstrated an AUC of 87 percent and sensitivity of 89 percent, according to new research.
